To treat or not to treat is the nagging question

Pediatrics

Volumn 125, Issue 1, 2010, Pages

  Yogev, Ram ^a   Pelton, Stephen ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; DEXAMETHASONE; GLYCEROL; HYDROGEN PEROXIDE; MACROLIDE; RIFAMPICIN; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BACTERIAL GROWTH; BACTERIAL MENINGITIS; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID; DELAYED DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFECT; DRUG RESPONSE; GLASGOW COMA SCALE; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HUMAN; MORBIDITY; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

DECISION MAKING; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MENINGITIS, HAEMOPHILUS; MENINGITIS, PNEUMOCOCCAL; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 74049113768     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-2915     Document Type: Note

References (16)

1. Peltola H, Roine I, Fernández J, et al. Hearing impairment in childhood bacterial meningitis little relieved by adjuvant dexamethasone or glycerol. Pediatrics. 2010;125(1). Available at: www.pediatrics.org/cgi/ content/full/125/1/e1
2. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211-218
3. van de Beck D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2007;(1):CD004405
4. McIntyre PH, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278(11):925-931
5. McCracken GH Jr. Rich nations, poor nations, and bacterial meningitis. Lancet. 2002;360(9328):183
6. Lebel MH, Hoyt MJ, McCracken GH Jr. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr. 1989;114(6):1049-1054
7. Kaplan SL, Smith EO, Wills C, Feigin RD. Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr Infect Dis. 1986;5(6):626-632
8. Bonsu BK, Harper MB. Fever interval before diagnosis, prior antibiotic treatment, and clinical outcome for young children with bacterial meningitis. Clin Infect Dis. 2001;32(4):566-572
9. McIntyre PB, MacIntyre CR, Gilmour R, Wang H. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child. 2005;90(4):391-396
10. Brandt CT, Holm D, Liptrot M, et al. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis. J Infect Dis. 2008;197(2):235-244
11. Roine I, Peltola H, Fernandez J, et al. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis. 2008;46(8):1248-1252
12. Bogdan I, Leib SL, Bergeron M, Chow L, Taüber MG. Tumor necrosis factor-α contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis. 1997;176(3):693-697
13. Hoffmann OM, Becker D, Weber JR. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. J Cereb Blood Flow Metab. 2007;27(11):1792-1797
14. Lutsar I, Friedland IR, Jafri S, et al. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother. 2003;52(4):651-655
15. Spreer A, Lugert R, Stoltefaut V, Hoecht A, Eiffer H, Nau R. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit Care Med. 2009;37(7):2253-2258
16. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med. 2001;161(15):1837-1842